Quick Summary
Igufighter 25mg Tablet
Last updated on 05 Aug 2026 | 05:35 AM (IST)
₹195
MRP: ₹214.69
(You Save ₹19.69)
10 TABLET(s) IN A STRIP
9% OFF
₹195
MRP: ₹214.69
Inclusive of all taxes
9% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Iguseas 25mg Tablet
OVERSEAS HEALTH...
₹ 24.40/tablet
26% costlier
Mimod 25mg Tablet
AJANTA PHARMA L...
₹ 26.00/tablet
34% costlier
Redimard 25mg Tablet
DR REDDY'S LABO...
₹ 27.10/tablet
39% costlier
Igurati 25mg Tablet
IPCA LABORATORI...
₹ 27.50/tablet
42% costlier
Introduction to Igufighter 25mg Tablet
Igufighter 25mg Tablet contains an active component of Iguratimod. It is a medication used for the treatment of rheumatoid arthritis and other autoimmune diseases like ankylosing spondylitis, psoriatic arthritis, systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA) and behçet's disease. It is an oral disease-modifying antirheumatic drug (DMARD) that helps to reduce inflammation and manage symptoms associated with these conditions. Ankylosing spondylitis is a chronic inflammatory arthritis primarily affecting the spine and pelvis. Psoriatic arthritis is an inflammatory arthritis that can affect joints, skin, and nails, often occurring in individuals with psoriasis. Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect various body parts, leading to inflammation, pain, and damage to organs and tissues. Juvenile Idiopathic Arthritis (JIA) is a type of arthritis that begins in childhood, causing joint inflammation and potentially affecting a child's overall health and growth. Behçet's Disease is a rare autoimmune disorder characterised by inflammation that can affect various body parts, leading to symptoms such as mouth and genital ulcers, skin lesions, and eye inflammation.
Be familiar with the signs and symptoms of hypersensitivity reactions, including skin rash, hives, itching, swelling (especially of the face, lips, or throat), difficulty breathing, and chest tightness. If you experience any of these symptoms, seek medical attention immediately. Inform your healthcare provider about known allergies, especially if you have had previous hypersensitivity reactions to medications. Igufighter 25mg Tablet is contraindicated in individuals with severe hepatic, renal, or significant haematological abnormalities. Avoiding Igufighter 25mg Tablet in these cases is important to prevent potential adverse reactions or complications. For children, this medication should be used under the guidance of a pediatric rheumatologist, with careful consideration of dosage, growth monitoring, and open communication with caregivers. Consulting a geriatric specialist is crucial for older adults to assess potential interactions, adjust dosages, and ensure regular follow-up while emphasising fall prevention, hydration, and nutrition to support safe and effective treatment.
Uses of Igufighter 25mg Tablet
Igufighter 25mg Tablet is used in the following:
- Rheumatoid arthritis
- Ankylosing spondylitis
- Psoriatic arthritis
- Systemic lupus erythematosus
- Juvenile idiopathic arthritis
- Behçet's disease
Therapeutic Effects of Igufighter 25mg Tablet
Iguratimod's mechanism of action involves suppressing the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-α, which contribute to autoimmune responses and inflammation. It may also modulate T cell activity, downregulate inflammatory mediators like COX-2 and MMPs, and influence immune cell activation, collectively reducing inflammation and mitigating damage caused by autoimmune diseases. Additionally, Its potential antioxidant properties could further contribute to its anti-inflammatory effects.
Interaction of Igufighter 25mg Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Igufighter 25mg Tablet, reducing effectiveness by causing undesirable side effects.
More Information about Igufighter 25mg Tablet
- Store at room temperature, between up to 20°C to 25°C (68°F to 77°F)
- Keep away from moisture, heat, and light.
- It should not be frozen.
How to consume Igufighter 25mg Tablet
Igufighter 25mg Tablet is typically administered orally, which means it is taken by mouth. It is available in the form of tablets or capsules that are ingested with water. Always follow your healthcare provider's instructions regarding the correct dosage, timing, and frequency of administration for this medication.
Safety Advice for Igufighter 25mg Tablet
Breast Feeding
Igufighter 25mg Tablet is not recommended while breastfeeding, as it is unknown if the drug passes into breast milk.
Alcohol
It is advisable to avoid or limit alcohol consumption while taking Igufighter 25mg Tablet, as alcohol can interact with medications and potentially increase the risk of side effects or complications.
Liver
If you have liver conditions, including hepatitis or cirrhosis, you should consult a healthcare provider before starting this medication.
Lungs
If you have lung conditions such as chronic obstructive pulmonary disease (COPD) or interstitial lung disease, consult your healthcare provider before starting Igufighter 25mg Tablet.
Driving
Igufighter 25mg Tablet is not known to impact driving or operating machinery significantly. However, always consult your healthcare provider if you experience dizziness, drowsiness, or any other side effects.
Pregnancy
Igufighter 25mg Tablet is not recommended during pregnancy. It is advised to avoid this medication. If you are pregnant or planning to become pregnant, the safety of the developing fetus has not been established.
Side Effects of Igufighter 25mg Tablet
Igufighter 25mg Tablet causes some side effects like all medications, although not everyone will experience them.
Serious:
- Liver Effects
- Hematologic Effects
- Allergic Reactions
- Gastrointestinal Issues
Common:
- Gastrointestinal upset
- Rash and skin reactions
- Elevated liver enzymes
- Upper respiratory tract infections
- Headache
- Fatigue
Word of Advice
Be careful for serious allergic reactions, particularly if rash, swelling, or breathing difficulties occur. Pregnant and breastfeeding individuals should avoid Igufighter 25mg Tablet. Use caution if you have lung, liver, cardiovascular, or eye conditions, and discuss bone health, immunisations, and mental health with your healthcare provider. Limit alcohol consumption, be cautious when driving and using machinery if drowsiness occurs, and protect your skin from sunlight. Communicate pre-existing medical conditions, infections, or surgery plans with your doctor. If you experience unusual symptoms, such as respiratory issues or mood changes, seek prompt medical attention. Follow dosing instructions consistently, attend follow-up appointments, and consult your doctor for personalised guidance based on your health profile.
FAQs about Igufighter 25mg Tablet
Q1.
Can Igufighter 25mg Tablet be used long-term?
Long-term use of Iguratimod may be necessary to manage chronic autoimmune conditions. Your healthcare provider will determine the appropriate duration of treatment based on your individual needs and response.
Q2.
Can Igufighter 25mg Tablet affect my vision?
While vision changes are not a common side effect, inform your healthcare provider if you experience any visual disturbances or eye discomfort.
Q3.
Is it safe to receive vaccinations while on Igufighter 25mg Tablet?
Consult your healthcare provider before receiving any vaccines while on Igufighter 25mg Tablet, as the medication may affect your immune response to vaccinations.
Q4.
Can I continue my regular physical activities and exercise routine while on Igufighter 25mg Tablet?
In general, you can continue your physical activities while taking Igufighter 25mg Tablet. However, if you experience joint pain or other symptoms, consult your doctor for guidance on adjusting your exercise routine.
Fact Box of Igufighter 25mg Tablet
| Molecule name: Iguratimod | Therapeutic class: Antirheumatic agents |
| Pharmacological class: Disease Modifying Anti-rheumatic Drugs (DMARDs) | Indications: 1. Rheumatoid Arthritis 2. Ankylosing spondylitis 3. Psoriatic arthritis 4. Systemic lupus erythematosus 5. Juvenile idiopathic arthritis |
References
- Huihui Jiang et al; Molecular mechanisms and clinical application of Iguratimod: A review; Biomedicine & Pharmacotherapy; Published on Feb 2020; Accessed on 09/08/2023; https://pubmed.ncbi.nlm.nih.gov/31918275/
- Novartis Pharmaceuticals UK Ltd, Electronic medicines compendium (emc), [Revised on 25th Jul 2022] [Accessed on 9th August 2023], https://www.medicines.org.uk/emc/product/6658/smpc#gref
- Sisi Xie et al; Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape; Frontiers in Pharmacology; Published on 26/02/2020; Accessed on; 09/08/2023 http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7054862/
- Jie Li et al; Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology; Bone Research; Published on Sept 2019; Accessed on 09/08/2023; http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6804744/
Disclaimer
MrMed’s primary intention is to ensure that its consumers get accurate and trustworthy information that is reviewed by experts. The contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship
Did you find this information helpful?
Author Details
Written By
Dr. Vijayalakshmi N.
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 05 Aug 2026 | 05:35 AM (IST)
Want to know more?
Read Our Editorial Policy